Newomics

Newomics is a private, commercial-stage company providing innovative hardware and consumables to improve the performance of mass spectrometry systems. Its core technology platform utilizes multi-nozzle microfluidic chips to split LC eluent into multiple electrosprays, dramatically increasing ionization efficiency and signal sensitivity. This addresses critical bottlenecks in proteomics, metabolomics, and clinical MS, positioning Newomics as an enabler for the broader adoption of LC-MS in translational and diagnostic settings. The company sells its UniESI sources, M3 emitters, and MEA chips directly to research and clinical laboratories.

Proprietary 'Multispray' microfluidic technology featuring multi-nozzle M3 emitters and integrated MEA chips. This platform enhances electrospray ionization efficiency for LC-MS, delivering significant gains in sensitivity, robustness, and throughput for microflow and nanoflow applications.

Newomics competes in the niche market for advanced LC-MS ion sources and consumables. Direct competitors include other specialized ion source manufacturers (e.g., Advion, Spectroswiss), while its broader competitive set includes the default sources provided by major MS instrument vendors (Thermo Fisher, Waters, Sciex, Bruker, Agilent). Its differentiation lies in its patented multinozzle technology and integrated MEA chip.